{
    "id": 25741,
    "fullName": "BIRC2 dec exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "BIRC2 dec exp indicates decreased expression of the Birc2 protein and/or mRNA. However, the mechanism causing the decreased expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 329,
        "geneSymbol": "BIRC2",
        "terms": [
            "BIRC2",
            "API1",
            "c-IAP1",
            "cIAP1",
            "Hiap-2",
            "HIAP2",
            "MIHB",
            "RNF48"
        ]
    },
    "variant": "dec exp",
    "createDate": "11/14/2016",
    "updateDate": "09/08/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 9220,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a head and neck squamous cell carcinoma cell line xenograft model with decreased expression of BIRC2 and FADD resulted in no benefit when treated with the combination of TL32711 (birinapant) and radiotherapy (PMID: 27469115).",
            "molecularProfile": {
                "id": 26788,
                "profileName": "BIRC2 dec exp FADD dec exp"
            },
            "therapy": {
                "id": 4953,
                "therapyName": "Birinapant + Radiotherapy",
                "synonyms": null
            },
            "indication": {
                "id": 5520,
                "name": "head and neck squamous cell carcinoma",
                "source": "DOID"
            },
            "responseType": "no benefit",
            "references": [
                {
                    "id": 7034,
                    "pubMedId": 27469115,
                    "title": "SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27469115"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26781,
            "profileName": "BIRC2 dec exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 26788,
            "profileName": "BIRC2 dec exp FADD dec exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}